533 related articles for article (PubMed ID: 19082706)
21. Proteomics Analysis Moves the Needle by Generating Clinical Diagnostic Markers.
Teunissen CE
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200256. PubMed ID: 38684037
[No Abstract] [Full Text] [Related]
22. Clinical proteomics and breast cancer.
Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer proteomics: a review for clinicians.
Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
[TBL] [Abstract][Full Text] [Related]
24. Decoding Hidden Messengers: Proteomic Profiling of Exosomes in Mammary Cancer Research.
Novais AA; Tamarindo GH; Chuffa LGA; Zuccari DAPC
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893211
[TBL] [Abstract][Full Text] [Related]
25. An Inflection Point in Cancer Protein Biomarkers: What was and What's Next.
Barker AD; Alba MM; Mallick P; Agus DB; Lee JSH
Mol Cell Proteomics; 2023 Jul; 22(7):100569. PubMed ID: 37196763
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST Study.
Hagenaars SC; Dekker LJM; Ravesteijn B; van Vlierberghe RLP; Romijn FPHTM; Verhoeff L; Witkamp AJ; Schenk KE; Keymeulen KBIM; Menke-Pluijmers MBE; Dassen AE; Kortmann BA; de Vries J; Rutgers EJT; van der Burgt YEM; Meershoek-Klein Kranenbarg E; Cobbaert CM; Luider TM; Mesker WE; Tollenaar RAEM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293255
[TBL] [Abstract][Full Text] [Related]
27. Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Gwark S; Ahn HS; Yeom J; Yu J; Oh Y; Jeong JH; Ahn JH; Jung KH; Kim SB; Lee HJ; Gong G; Lee SB; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Kim K; Kim J
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944885
[TBL] [Abstract][Full Text] [Related]
28. Molecular Histology Analysis of Cryopreserved Tissue Using Peptide/Protein MALDI-TOF Imaging Mass Spectrometry (MALDI-IMS).
Iloro I; Escobés I; Azkargorta M; Elortza F
Methods Mol Biol; 2022; 2420():177-190. PubMed ID: 34905174
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive overview of proteomics approach for COVID 19: new perspectives in target therapy strategies.
Rana R; Rathi V; Ganguly NK
J Proteins Proteom; 2020; 11(4):223-232. PubMed ID: 33162722
[TBL] [Abstract][Full Text] [Related]
30. iTRAQ-based proteomics monitors the withering dynamics in postharvest leaves of tea plant (Camellia sinensis).
Wu ZJ; Ma HY; Zhuang J
Mol Genet Genomics; 2018 Feb; 293(1):45-59. PubMed ID: 28852881
[TBL] [Abstract][Full Text] [Related]
31. Current advances in biomarkers for targeted therapy in triple-negative breast cancer.
Fleisher B; Clarke C; Ait-Oudhia S
Breast Cancer (Dove Med Press); 2016; 8():183-197. PubMed ID: 27785100
[TBL] [Abstract][Full Text] [Related]
32. Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.
Yao F; Zhang C; Du W; Liu C; Xu Y
PLoS One; 2015; 10(9):e0138213. PubMed ID: 26375396
[TBL] [Abstract][Full Text] [Related]
33. Enhancing MALDI time-of-flight mass spectrometer performance through spectrum averaging.
Mitchell M; Mali S; King CC; Bark SJ
PLoS One; 2015; 10(3):e0120932. PubMed ID: 25798583
[TBL] [Abstract][Full Text] [Related]
34. Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.
Opstal-van Winden AW; Beijnen JH; Loof A; van Heerde WL; Vermeulen R; Peeters PH; van Gils CH
J Clin Lab Anal; 2012 Jan; 26(1):1-9. PubMed ID: 24833528
[TBL] [Abstract][Full Text] [Related]
35. Implications of functional proteomics in breast cancer.
Chae YK; Gonzalez-Angulo AM
Oncologist; 2014 Apr; 19(4):328-35. PubMed ID: 24664486
[TBL] [Abstract][Full Text] [Related]
36. Endobiogeny: a global approach to systems biology (part 1 of 2).
Lapraz JC; Hedayat KM
Glob Adv Health Med; 2013 Jan; 2(1):64-78. PubMed ID: 24381827
[TBL] [Abstract][Full Text] [Related]
37. Optimal management of bone metastases in breast cancer patients.
Wong M; Pavlakis N
Breast Cancer (Dove Med Press); 2011 May; 3():35-60. PubMed ID: 24367175
[TBL] [Abstract][Full Text] [Related]
38. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry technology for the diagnosis of colorectal adenoma.
Zhou ZY; Tao DD; Cao JW; Luo HS
Oncol Lett; 2013 Jun; 5(6):1935-1938. PubMed ID: 23833670
[TBL] [Abstract][Full Text] [Related]
39. Fluopsin C induces oncosis of human breast adenocarcinoma cells.
Ma LS; Jiang CY; Cui M; Lu R; Liu SS; Zheng BB; Li L; Li X
Acta Pharmacol Sin; 2013 Aug; 34(8):1093-100. PubMed ID: 23708552
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
